Before you sell to, join or invest in BTB Therapeutics, Inc.
MentionFox check on BTB Therapeutics, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/btb-therapeutics-inc-form-d-25000002
Check BTB Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
BTB Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-05.
BTB Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 5, 2025. The filing reports $3.33M sold. Its industry group is Pharmaceuticals. It names Takashi Kiyoizumi (Executive Officer, Director) (SEC Form D, February 5, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like BTB Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns BTB Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind BTB Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in California, filed within 90 days of this one, largest first.
Get an email when BTB Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when BTB Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch BTB Therapeutics, Inc. →Get the full cited report on BTB Therapeutics, Inc.
What the filing shows about BTB Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on BTB Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives BTB Therapeutics, Inc.'s address as 26281 Wyndemere Court, Escondido, CA 92026.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for BTB Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
BTB Therapeutics, Inc. is a registered filer with the SEC (CIK 2055053) and has filed since 2025-02-05. 3 filings are on record, the latest on 2026-08-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
BTB Therapeutics, Inc.'s Form D of 2025-02-05 names Takashi Kiyoizumi as its officers, directors or promoters.
Its new offerings report $6.74M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Takashi Kiyoizumi is named as Executive Officer and Director on the Form D that BTB Therapeutics, Inc. filed with the SEC on 5 February 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-02-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about BTB Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on BTB Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BTB Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BTB Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind BTB Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for BTB Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/btb-therapeutics-inc-form-d-25000002